Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

Table 4 Risk factors for 30 day mortality in patients treated with carbapenems

	Univariate analysis	Multivariate analysis	Univariate analysis	Multivariate analysis
Variables	P	HR (95%CI), P	Adjusted P	Adjusted HR (95%CI), P
Age	0.021	0.94 (0.90–0.98), 0.005	0.254
Leukemia	0.064	8.64 (1.60–46.47), 0.012	0.036	11.35 (1.17–109.83), 0.036
Pitt bacteremia score	0.320	1.45 (1.08–1.96), 0.014	0.969
aCCI	0.640		0.794
SOFA score	0.731		0.462	0.74 (0.38–1.44), 0.378

ISSN: 1476-0711